DNLI

18.4401.32%
AO

Alexander O. Schuth

Co-Founder, CFO, COO & Secretary

Dr. Alexander O. Schuth, also known as Alex, M.D., Ph.D., is Director of Molecular Health GmbH. Dr. Schuth has been Chief Financial Officer of Denali Therapeutics Inc. since May 01, 2022. He is the Founder of Denali Therapeutics Inc. He has been Chief Operating Officer of Denali Therapeutics Inc. since March 2015 and has been its Secretary since June 2015. He co-founded and joined Denali from Genentech, where he held various roles of increasing responsibility between 2005 and 2015; from September 2014 to March 2015, he served as Head of Technology Innovation and Diagnostics Partnering; from March 2010 to September 2014, he served as Head of Neuroscience Partnering; from January 2007 to March 2010, he worked in the business development team; and from August 2005 to January 2007, he worked as an R&D finance Manager. From January 2001 to May 2003, he served as Investment Banking Associate in the equity capital markets group at Merrill Lynch in London. He serves on the Board of Directors of Molecular Health, a privately held biopharmaceutical company. He received his M.B.A. from The Wharton School of the University of Pennsylvania and his M.D. at the Charite Medical School at the Humboldt University in Berlin, Germany.

Positions